3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Colorectal Neoplasms
44
Pancreatic Neoplasms
39
Rectal Neoplasms
20
Colonic Neoplasms
19
Stomach Neoplasms
18
Neoplasm Metastasis
16
Esophageal Neoplasms
13
Cholangiocarcinoma
13
Barrett Esophagus
11
Carcinoma, Hepatocellular
10
Ovarian Neoplasms
9
Breast Neoplasms
9
Adenocarcinoma Of Esophagus
9
Melanoma
8
Anus Neoplasms
8
Neoplasms
7
Sarcoma
6
Lung Neoplasms
6
Liver Neoplasms
6
Glioma
6
Gastroesophageal Reflux
6
Gallbladder Neoplasms
6
Uterine Cervical Neoplasms
5
Lymphoma, Non-Hodgkin
5
Hepatoblastoma
5
Esophageal Squamous Cell Carcinoma
5
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Adenomatous Polyposis Coli
5
Wilms Tumor
4
Interventions
pembrolizumab
25
Nivolumab
20
atezolizumab
8
Magnetic Resonance Spectroscopy
7
Ipilimumab
7
Specimen Handling
5
Paclitaxel
5
Fluorodeoxyglucose F18
4
Cyclophosphamide
4
Carboplatin
4
fludarabine
3
durvalumab
3
avelumab
3
Interleukin-2
3
Gemcitabine
3
Docetaxel
3
130-nm albumin-bound paclitaxel
3
tislelizumab
2
spartalizumab
2
regorafenib
2
epacadostat
2
cabozantinib
2
aldesleukin
2
Taxes
2
Pemetrexed
2
FAPI-46
2
Cisplatin
2
Albumin-Bound Paclitaxel
2
zanidatamab
1
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
Biopsy
×
Gastrointestinal
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled